Walgreens Boots Alliance shares are trading lower after the company settled an opioid lawsuit in San Francisco for $230 million.
Portfolio Pulse from Benzinga Newsdesk
Walgreens Boots Alliance (WBA) has settled an opioid lawsuit in San Francisco for $230 million, causing its shares to trade lower.
May 18, 2023 | 4:51 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Walgreens Boots Alliance's stock price is trading lower after settling an opioid lawsuit for $230 million.
The settlement of the opioid lawsuit for $230 million is a significant financial burden for Walgreens Boots Alliance, which is causing its stock price to trade lower. Investors may be concerned about the company's financial health and potential future legal issues.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100